366 related articles for article (PubMed ID: 32502665)
1. The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii.
Katip W; Uitrakul S; Oberdorfer P
Int J Infect Dis; 2020 Aug; 97():391-395. PubMed ID: 32502665
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Nephrotoxicity of Loading Dose Colistin-Meropenem versus Loading Dose Colistin-Imipenem in the Treatment of Carbapenem-Resistant
Katip W; Oberdorfer P; Kasatpibal N
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745838
[TBL] [Abstract][Full Text] [Related]
3. High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
Nazer LH; Rihani S; Hawari FI; Le J
Infect Dis (Lond); 2015; 47(11):755-60. PubMed ID: 26050703
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant
Katip W; Uitrakul S; Oberdorfer P
Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 32998187
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia.
Alp E; Eren E; Elay G; Cevahir F; Esmaoğlu A; Rello J
Infez Med; 2017 Dec; 25(4):311-319. PubMed ID: 29286009
[TBL] [Abstract][Full Text] [Related]
7.
Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
[TBL] [Abstract][Full Text] [Related]
8. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
[TBL] [Abstract][Full Text] [Related]
9. Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial.
Dickstein Y; Lellouche J; Ben Dalak Amar M; Schwartz D; Nutman A; Daitch V; Yahav D; Leibovici L; Skiada A; Antoniadou A; Daikos GL; Andini R; Zampino R; Durante-Mangoni E; Mouton JW; Friberg LE; Dishon Benattar Y; Bitterman R; Neuberger A; Carmeli Y; Paul M;
Clin Infect Dis; 2019 Aug; 69(5):769-776. PubMed ID: 30462182
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: A systematic review and meta-analysis.
Wang J; Niu H; Wang R; Cai Y
Int J Antimicrob Agents; 2019 Apr; 53(4):383-400. PubMed ID: 30447379
[TBL] [Abstract][Full Text] [Related]
11. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
[TBL] [Abstract][Full Text] [Related]
12. Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model.
Liu X; Zhao M; Chen Y; Bian X; Li Y; Shi J; Zhang J
Int J Antimicrob Agents; 2016 Nov; 48(5):559-563. PubMed ID: 27670371
[TBL] [Abstract][Full Text] [Related]
13. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
Yilmaz GR; Guven T; Guner R; Kocak Tufan Z; Izdes S; Tasyaran MA; Acikgoz ZC
J Infect Dev Ctries; 2015 May; 9(5):476-85. PubMed ID: 25989167
[TBL] [Abstract][Full Text] [Related]
14. Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant
Katip W; Uitrakul S; Oberdorfer P
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056926
[TBL] [Abstract][Full Text] [Related]
15. The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital.
Li KL; Abad CLR
Int J Infect Dis; 2020 Apr; 93():9-14. PubMed ID: 31978579
[TBL] [Abstract][Full Text] [Related]
16. Survival of carbapenem-resistant
Park SY; Si HJ; Eom JS; Lee JS
J Int Med Res; 2019 Dec; 47(12):5977-5985. PubMed ID: 31612764
[TBL] [Abstract][Full Text] [Related]
17. Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes.
Kwon KH; Oh JY; Yoon YS; Jeong YJ; Kim KS; Shin SJ; Chung JW; Huh HJ; Chae SL; Park SY
Int J Antimicrob Agents; 2015 Jun; 45(6):605-9. PubMed ID: 25772644
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
Ni W; Wang Y; Ma X; He Y; Zhao J; Guan J; Li Y; Gao Z
Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1451-1457. PubMed ID: 36201141
[TBL] [Abstract][Full Text] [Related]
19. Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study.
Katip W; Rayanakorn A; Oberdorfer P; Taruangsri P; Nampuan T
J Infect Public Health; 2023 Aug; 16(8):1249-1255. PubMed ID: 37295057
[TBL] [Abstract][Full Text] [Related]
20. Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections.
Sirijatuphat R; Thamlikitkul V
Antimicrob Agents Chemother; 2014 Sep; 58(9):5598-601. PubMed ID: 24982065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
